2025-01-15

Congratulations to Bárbara on her first article, recently accepted by Pharmaceuticals! This study discuss how the incorporation of (iso)nicotinic acid-based ligands influences the cytotoxicity of RuCp organometallic complexes.

2024-12-02

We ended the year with great news!!  Bárbara Marques successfully defended her thesis titled “Smart Metallodrugs as Theranostic Agents for Precision Therapy in Breast Cancer”. Congratulations, Bárbara!

2024-10-02

We had the opportunity to present our Arrows2Cancer project at Tec Labs FCUL during its open day. Tec Labs' Demo Day was a vibrant event, filled with inspiration, innovation, and transformative ideas.

2024-09-30

In this perspective article, we explore the potential of metal complexes as catalysts in revolutionizing anticancer therapies and opening new pathways for therapeutic innovation. 

2024-06-27

Bárbara Marques was honored with the Best Flash Pitch award at the Chem & Biochem Students Meeting for her Master’s thesis, “Smart Metallodrugs as Theranostic Agents for Precision Therapy in Breast Cancer.” This recognition highlights her innovative research in the field of precision cancer therapy. Congratulations, Bárbara! 

2024-06-19

Marco Sá received an Honorable Mention for his excellent oral communication at CQE Days 2024. Congratulations to Marco!

2024-06-19

Most of the Morais Group members participated in CQE Days 2024, presenting oral and poster presentations. 

2024-06-05

The Portuguese Association of Cancer Research has just highlighted our research on the first CoCp complexes with cancer-selective properties. This study was conducted in collaboration with Paulo Costa, Alexandra Fernandes, and Pedro Baptista. 

2024-05-19

Bárbara Marques was honored with the Best Poster Presentation award at the 2024 Inorganic & Bioinorganic Chemistry Conference (2024IBiCC), showcasing the quality of her graduation work.  Congratulations Bárbara!

2024-05-19

Tânia Morais delivered a keynote presentation at the 2024IBiCC, focusing on her research into smart drug delivery systems for the precision treatment of cancer. 

2024-05-07

Great news! Our recent article, titled “Dual FGFR-Targeting and pH-Activatable Ruthenium–Peptide Conjugates for Targeted Therapy of Breast Cancer,” published in Dalton Transactions, has been honored with the front cover of its issue! 

2024-04-30

João Franco Machado successfully defended his PhD thesis, and we wish him all the best for his future endeavors. Thanks to the defense committee members: Pedro Gois, Carlos Lodeiro, Paula Robalo, and Andreia Valente. 

2024-04-13

Tânia Morais delivered a keynote presentation at the 1st International Caparica Conference on Prescriptomics and Precision Medicine.

2024-03-26

Our article, titled “Dual FGFR-Targeting and pH-Activatable Ruthenium–Peptide Conjugates for Targeted Therapy of Breast Cancer” presents the first smart metallodrug delivery systems developed for the precision treatment of FGFR-positive breast cancers. 

2024-03-19

Our article, presenting the first CoCp complexes for cancer therapy, has just been accepted in Inorganic Chemistry. These compounds demonstrate high in vitro activity while exhibiting no toxicity or adverse effects in vivo, as shown in a chick embryo chorioallantoic membrane model. 

2023-07-24

Marco Sá successfully defended his MSc thesis under the Arrows2cancer project. Thanks to the defense committee members: João António and Susana Santos. 

2023-05-11

Exciting news! Our paper, "Copper(I) Complexes as Dual Anticancer and Antiparasitic Agents," has been selected as a VIP paper and featured on the ChemistryViews website. 

2022-11-25

We were pleased to welcome our consultant, Angela Casini, to our lab during her recent visit. It was a valuable opportunity to discuss ongoing projects, exchange ideas, and gain insights from her expertise. We look forward to continued collaboration and future visits! 

2022-05-27

Exciting news! João Machado has been awarded the prize for Best Oral Communication at CQE Days 2022.